ISSN:
1432-1335
Keywords:
Yoshida sarcoma
;
Tumor-bearing host
;
Branched-chain amino acids
;
l-leucine
;
l-isoleucine
;
l-valine
;
Excretion of α-ketoglutarate
;
Urea
;
Creatinine
;
Uric acid
;
Nitrogen balance
;
Food consumption
;
Survival time
;
Carcass protein
;
Gastrocnemius muscle
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Summary The continuous administration of physiological doses of the branched-chain amino acids leucine, isoleucine, and valine (Leu-Ile-Val) to Yoshida sarcoma-bearing rats caused a significant increase in the survival time by 32% and a significant reduction of tumor size after 3 weeks of growth by 33%. The shift of the nitrogen balance to negative values during the cachectic stage was delayed but not prevented. On the average, less nitrogen (-47 mg/day) were lost by Leu-Ile-Val treated rats compared with untreated tumor-bearing animals (-91 mg N/day). It appeared that Leu-Ile-Val increased the synthesis of carcass proteins, while it left the proteolysis rate unchanged, since the excretion of urea and creatinine was unaffected by these amino acids. The daily excretion of α-ketoglutarate, which is correlated with tumor size during the early stage of growth, was decreased during the first 2 weeks by Leu-Ile-Val, but remained for a longer period on a high level than in untreated tumor bearers. The results point to an improvement of the metabolic resistance against carcass protein depletion of the tumor-bearing host by the administration of branched-chain amino acids.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1007/BF00405780
Permalink
